For a slew of AI chip companies chomping to dethrone Nvidia, DeepSeek is the opening they’ve been waiting for.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. "We'll hopefully have some AI-designed drugs in clinical trials by the end of the year,

Some AI researchers hailed DeepSeek’s R1 as a breakthrough on the same level as DeepMind’s AlphaZero, a 2017 model that became superhuman at the board games Chess and Go by purely playing against itself and improving, rather than observing any human games.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll hopefully have

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

This new approach, based on natural selection, dramatically improves the reliability of large language models for practical tasks like trip planning. Here's how it works.

The persistent challenge of AI hallucinations - where artificial intelligence systems generate false or misleading information.

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

The company fulfilled requests from Israel’s military for more access to AI tools as it sought to compete with Amazon, documents obtained by The Post show.

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.

Currently, graduates from the Indian Institutes of Technology and Carnegie Mellon University in the US do not qualify for the UK’s High Potential Individual visa.